Article
Biochemical and virological outcome of patients with chronic hepatitis C treated with interferon alfa-2b for 6 or 12 months: a 4-year follow-up of 211 patients.
Hepatology (Baltimore, Md.) - 1 Sept 1997
Manesis E K, Papaioannou C, Gioustozi A, Kafiri G, Koskinas J, Hadziyannis S J
Abstract excerpt
To compare two interferon (IFN) schedules for the treatment of chronic hepatitis C, we followed 211 patients who received 3 million units IFN-alpha2b thrice weekly for either 6 months (group 1; 85 patients) or 12 months (group 2; 126 patients), with a median follow-up of 3.4 (0.1-8.4) and 4.2 (0....
Topics
- Adolescent
- Adult
- Aged
- Discriminant Analysis
- Dose-Response Relationship, Drug
- Female
- Follow-Up Studies
- Genotype
- Hepacivirus
- Hepatitis C
- Humans
- Interferon alpha-2
- Interferon-alpha
- Liver Function Tests
- Male
- Middle Aged
- Multivariate Analysis
- Probability